Genesys Capital — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Inversagoinversago.comOct 2022acquired by Novo Nordisk
Portfolio company acquired by Novo Nordisk for $1.1B USD.
Co-investorsAmorChemJDRF T1D FundNew Enterprise Associates (NEA)Tarnagulla VenturesadMare BioInnovationsAmgen Ventures+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.